Some patient advocates from the NCCN Guidelines Panels who make evidence-based expert consensus-driven recommendations for ...

Mary B. Daly, MD, PhD, FACP, Fox Chase Cancer Center; and Chair of the NCCN Guidelines ® Panel for Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate The new NCCN Gu ...

Natera (NTRA) commented on recent updates by the NCCN on circulating tumor DNA molecular residual disease testing in the Clinical Practice ...

Daly, MD, PhD, FACP, Fox Chase Cancer Center; and chair of the NCCN Guidelines Panel for Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Cancer, said in a statement.

CORONADO, Calif. — Despite recent advances in the treatment of cutaneous squamous cell carcinoma (SCC), a lack of consensus ...

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has released a new resource aimed at helping individuals understand genetic testing and counseling for hereditary cancers.

A multilevel, navigation-based intervention led to more timely initiation of postoperative radiation therapy vs. usual ...

World Cancer Day also marks the start of the ‘United by Unique’ campaign, which seeks to highlight how each person’s journey ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) ...

NCCN has long worked to advance people-centered cancer care. The organization publishes the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®)—evidence-based expert consensus ...

The National Comprehensive Cancer Network joins a global day of advocacy to put people's individual needs and stories at the forefront of cancer care. NCCN Logo (C ...